Nanomolar and micromolar effects of 15-deoxy-Δ12,14- prostaglandin J2 on amnion-derived WISH epithelial cells: Differential roles of peroxisome proliferator-activated receptors γ and δ and nuclear factor κB

Molecular Pharmacology

Volumn 68, Issue 1, 2005, Pages 169-178

  Berry, Elicia B E ^a   Keelan, Jeffrey A ^a,b   Helliwell, Rachel J A ^b   Stewart Gilmour, R ^a   Mitchell, Murray D ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; BENZAMIDE DERIVATIVE; CYCLOOXYGENASE 2; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; UNCLASSIFIED DRUG;

AMNION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMNION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; NANOTECHNOLOGY; NF-KAPPA B; PPAR DELTA; PPAR GAMMA; PROSTAGLANDIN D2;

EID: 22344434292     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.009449     Document Type: Article

References (77)

1. Asada K, Sasaki S, Suda T, Chida K, and Nakamura H (2004) Antiinflammatory roles of peroxisome proliferator-activated receptor gamma in human alveolar macrophages. Am J Respir Crit Care Med 169:195-200.
2. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, and Evans RM (1999) PPAR gamma is required for placental, cardiac and adipose tissue development. Mol Cell 4:585-595.
3. Barbieri SS, Cavalca V, Eligini S, Brambilla M, Caiani A, Tremoli E, and Colli S (2004) Apocynin prevents cyclooxygenase 2 expression in human monocytes through NADPH oxidase and glutathione redox-dependent mechanisms. Free Radic Biol Med 37:156-165.
4. Bell-Parikh LC, Ide T, Lawson JA, McNamara P, Reilly M, and FitzGerald GA (2003) Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Investig 112:945-955.
5. Berger J, Patel HV, Woods J, Hayes NS, Parent SA, Clemas J, Leibowitz MD, Elbrecht A, Rachubinski RA, Capone JP, et al. (2000) A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus. Mol Cell Endocrinol 162:57-67.
6. Berry EB, Eykholt R, Helliwell RJ, Gilmour RS, Mitchell MD, and Marvin KW (2003) Peroxisome proliferator-activated receptor isoform expression changes in human gestational tissues with labor at term. Mol Pharmacol 64:1586-1590.
7. Berryman GK, Strickland DM, Hankins GD, and Mitchell MD (1987) Amniotic fluid prostaglandin D2 in spontaneous and augmented labor. Life Sci 41:1611-1614.
8. Bishop-Bailey D and Hla T (1999) Endothelial cell apoptosis induced by the peroxisome proliferator- activated receptor (PPAR) ligand 15-deoxy-Δ12,14-prostaglandin J2. J Biol Chem 274:17042-17048.
9. Bowen JM, Chamley L, Keelan JA, and Mitchell MD (2002) Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition. Placenta 23:257-273.
10. Boyault S, Simonin MA, Bianchi A, Compe E, Liagre B, Mainard D, Becuwe P, Dauca M, Netter P, Terlain B, et al. (2001) 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways. FEBS Lett 501:24-30.
11. Camp HS and Tafuri SR (1997) Regulation of peroxisome proliferator-activated receptor γ activity by mitogen-activated protein kinase. J Biol Chem 272:10811-10816.
12. Cernuda-Morollon E, Pineda-Molina E, Canada FJ, and Perez-Sala D (2001) 15-Deoxy-Δ12,14-prostaglandin J2 inhibition of NF-κB-DNA binding through covalent modification of the p50 subunit. J Biol Chem 276:35530-35536.
13. Chen F, Wang M, O'Connor JP, He M, Tripathi T, and Harrison LE (2003) Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappabeta. J Cell Biochem 90:732-744.
14. Chen GG, Lee JF, Wang SH, Chan UP, Ip PC, and Lau WY (2002) Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer. Life Sci 70:2631-2646.
15. Chinery R, Coffey RJ, Graves-Deal R, Kirkland SC, Sanchez SC, Zackert WE, Oates JA, and Morrow JD (1999) Prostaglandin J2 and 15-deoxy-delta12,14- prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells. Cancer Res 59:2739-2746.
16. Colville-Nash PR, Qureshi SS, Willis D, and Willoughby DA (1998) Inhibition of inducible nitric oxide synthase by peroxisome proliferator- activated receptor agonists: correlation with induction of heme oxygenase 1. J Immunol 161:978-984.
17. Daynes RA and Jones DC (2002) Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol 2:748-759.
18. 2 ameliorates experimental autoimmune encephalomyelitis. J Immunol 168:2508-2515.
19. Draper D, McGregor J, Hall J, Jones W, Beutz M, Heine RP, and Porreco R (1995) Elevated protease activities in human amnion and chorion correlate with preterm premature rupture of membranes. Am J Obstet Gynecol 173:1506-1512.
20. Dudley DJ, Collmer D, Mitchell MD, and Trautman MS (1996) Inflammatory cytokine mRNA in human gestational tissues: implications for term and preterm labor. J Soc Gynecol Investig 3:328-335.
21. Dunn-Albanese LR, Ackerman WEt, Xie Y, Iams JD, and Kniss DA (2004) Reciprocal expression of peroxisome proliferator-activated receptor-gamma and cyclooxygenase-2 in human term parturition. Am J Obstet Gynecol 190:809-816.
22. 2 on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells. Biochem Pharmacol 67:1259-1267.
23. Ferry G, Bruneau V, Beauverger P, Goussard M, Rodriguez M, Lamamy V, Dromaint S, Canet E, Galizzi JP, and Boutin JA (2001) Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands. Eur J Pharmacol 417:77-89.
24. Fitzpatrick FA and Wynalda MA (1983) Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J Biol Chem 258:11713-11718.
25. Forman BM, Chen J, and Evans RM (1997) Hypolipidemic drugs, polyunsaturated fatty acids and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci USA 94:4312-4317.
26. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, and Evans RM (1995) 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812.
27. Hansen WR, Keelan JA, Skinner SJ, and Mitchell MD (1999) Key enzymes of prostaglandin biosynthesis and metabolism. Coordinate regulation of expression by cytokines in gestational tissues: a review. Prostaglandins Other Lipid Mediat 57:243-257.
28. Harris SG, Padilla J, Koumas L, Ray D, and Phipps RP (2002) Prostaglandins as modulators of immunity. Trends Immunol 23:144-150.
29. Hashimoto K, Ethridge RT, and Evers BM (2002) Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. Int J Gastrointest Cancer 32:7-22.
30. Helliwell RJA, Adams LA, and Mitchell MD (2004a) Prostaglandin synthases: recent developments and a novel hypothesis. Prostaglandins Leukot Essent Fatty Acids 70:101-113.
31. Helliwell RJA, Berry EBE, O'Carroll SJ, and Mitchell MD (2004b) Nuclear prostaglandin receptors: role in pregnancy and parturition? Prostaglandins Leukot Essent Fatty Acids 70:149-165.
32. Hortelano S, Castrillo A, Alvarez AM, and Bosca L (2000) Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages. J Immunol 165:6525-6531.
33. Inoue H, Tanabe T, and Umesono K (2000) Feedback control of cyclooxygenase-2 expression through PPARγ. J Biol Chem 275:28028-28032.
34. Jiang C, Ting AT, and Seed B (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature (Lond) 391:82-86.
35. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Investig 106:189-197.
36. Keelan J, Helliwell R, Nijmeijer B, Berry E, Sato T, Marvin K, Mitchell M, and Gilmour R (2001) 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis in amnion-like WISH cells. Prostaglandins Other Lipid Mediat 66:265-282.
37. Keelan JA, Blumenstein M, Helliwell RJ, Sato TA, Marvin KW, and Mitchell MD (2003) Cytokines, prostaglandins and parturition - a review. Placenta 24 (Suppl A):S33-S46.
38. Keelan JA, Marvin KW, Sato TA, Coleman M, McCowan LM, and Mitchell MD (1999a) Cytokine abundance in placental tissues: evidence of inflammatory activation in gestational membranes with term and preterm parturition. Am J Obstet Gynecol 181:1530-1536.
39. 2, a ligand for peroxisome proliferatoractivated receptor-gamma, induces apoptosis in JEG3 choriocarcinoma cells. Biochem Biophys Res Commun 262:579-585.
40. Kikawa Y, Narumiya S, Fukushima M, Wakatsuka H, and Hayaishi O (1984) 9-Deoxy-γ9, Δ12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. Proc Natl Acad Sci USA 81:1317-1321.
41. Kim IK, Lee JH, Sohn HW, Kim HS, and Kim SH (1993) Prostaglandin A2 and delta 12-prostaglandin J2 induce apoptosis in L1210 cells. FEBS Lett 321:209-214.
42. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, and Lehmann JM (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813-819.
43. Kniss DA (1999) Cyclooxygenases in reproductive medicine and biology. J Soc Gynecol Investig 6:285-292.
44. 2 and troglitazone. J Clin Endocrinol Metab 87:4667-4672.
45. Lawrence T, Willoughby DA, and Gilroy DW (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2:787-795.
46. Li M, Pascual G, and Glass CK (2000) Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol 20:4699-4707.
47. Marvin KW, Eykholt RL, Keelan JA, Sato TA, and Mitchell MD (2000) The 15-deoxydelta( 12,14)-prostaglandin J(2)receptor, peroxisome proliferator activated receptor-gamma (PPARgamma) is expressed in human gestational tissues and is functionally active in JEG3 choriocarcinoma cells. Placenta 21:436-440.
48. Mendez M and LaPointe MC (2003) PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase and inducible nitric oxide synthase in cardiac myocytes. Hypertension 42:844-850.
49. Mercurio F and Manning AM (1999) Multiple signals converging on NFkB. Curr Opin Cell Biol 11:226-232.
50. Mitchell MD, Flint AP, Bibby J, Brunt J, Arnold JM, Anderson AB, and Turnbull AC (1978a) Plasma concentrations of prostaglandins during late human pregnancy: influence of normal and preterm labor. J Clin Endocrinol Metab 46:947-951.
51. Mitchell MD, Kraemer DL, and Strickland DM (1982) The human placenta: a major source of prostaglandin D2. Prostaglandins Leukot Med 8:383-387.
52. Mitchell MD, Lucas A, Etches PC, Brunt JD, and Turnbull AC (1978b) Plasma prostaglandin levels during early neonatal life following term and pre-term delivery. Prostaglandins 16:319-326.
53. Mitchell MD, Romero RJ, Edwin SS, and Trautman MS (1995) Prostaglandins and parturition. Reprod Fertil Dev 7:623-632.
54. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, Kojima F, Ikeda T, Fueki M, Ueno A, Oh S, et al. (2000) Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 275:32783-32792.
55. Pavan B, Fiorini S, Ferretti ME, Vesce F, and Biondi C (2003a) WISH cells as a model for the "in vitro" study of amnion pathophysiology. Curr Drug Targets Immune Endocr Metabol Disord 3:83-92.
56. Pavan L, Tarrade A, Hermouet A, Delouis C, Titeux M, Vidaud M, Therond P, Evain-Brion D, and Fournier T (2003b) Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process. Carcinogenesis 24:1325-1336.
57. Petrova TV, Akama KT, and Van Eldik LJ (1999) Cyclopentenone prostaglandins suppress activation of microglia: down- regulation of inducible nitric-oxide synthase by 15-deoxy-Δ12,14-prostaglandin J2. Proc Natl Acad Sci USA 96:4668-4673.
58. Rauk PN and Chiao JP (2000) Interleukin-1 stimulates human uterine prostaglandin production through induction of cyclooxygenase-2 expression. Am J Reprod Immunol 43:152-159.
59. Reilly CM, Oates JC, Cook JA, Morrow JD, Halushka PV, and Gilkeson GS (2000) Inhibition of mesangial cell nitric oxide in MRL/lpr mice by prostaglandin J2 and proliferator activation receptor-gamma agonists. J Immunol 164:1498-1504.
60. Relic B, Benoit V, Franchimont N, Ribbens C, Kaiser MJ, Gillet P, Merville MP, Bours V, and Malaise MG (2004) 15-Deoxy-Δ12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. J Biol Chem 279:22399-22403.
61. Ricote M, Li AC, Willson TM, Kelly CJ, and Glass CK (1998) The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature (Lond) 391:79-82.
62. Rohn TT, Wong SM, Cotman CW, and Cribbs DH (2001) 15-Deoxy-delta12,14- prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis. Neuroreport 12:839-843.
63. Romero R, Baumann P, Gomez R, Salafia C, Rittenhouse L, Barberio D, Behnke E, Cotton DB, and Mitchell MD (1993) The relationship between spontaneous rupture of membranes, labor and microbial invasion of the amniotic cavity and amniotic fluid concentrations of prostaglandins and thromboxane B2 in term pregnancy. Am J Obstet Gynecol 168:1654-1668.
64. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, and Santoro MG (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature (Lond) 403:103-108.
65. Rovin BH, Wilmer WA, Lu L, Doseff AI, Dixon C, Kotur M, and Hilbelink T (2002) 15-Deoxy-delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death. Kidney Int 61:1293-1302.
66. Ruiz PA, Kim SC, Sartor RB, and Haller D (2004) 15-Deoxy-Δ12,14- prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity. J Biol Chem 279:36103-36111.
67. Sanchez-Gomez FJ, Cernuda-Morollon E, Stamatakis K, and Perez-Sala D (2004) Protein thiol modification by 15-deoxy-Δ12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. Mol Pharmacol 66:1349-1358.
68. Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, and Kikkawa R (2002) 15-Deoxy-delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells. Kidney Int 61:1957-1967.
69. Schaiff WT, Carlson MG, Smith SD, Levy R, Nelson DM, and Sadovsky Y (2000) Peroxisome proliferator-activated receptor gamma modulates differentiation of human trophoblast in a ligand-specific manner. J Clin Endocrinol Metab 85:3874-3881.
70. Shibata T, Kondo M, Osawa T, Shibata N, Kobayashi M, and Uchida K (2002) 15-Deoxy-Δ12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J Biol Chem 277:10459-10466.
71. Simpson KL, Keelan JA, and Mitchell MD (1998) Labor-associated changes in interleukin-10 production and its regulation by immunomodulators in human choriodecidua. J Clin Endocrinol Metab 83:4332-4337.
72. So T, Ito A, Sato T, Mori Y, and Hirakawa S (1992) Tumor necrosis factor-alpha stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells. Biol Reprod 46:772-778.
73. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, and Glass CK (2000) 15-deoxy-Δ12,14- prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway. Proc Natl Acad Sci USA 97:4844-4849.
74. Tarrade A, Schoonjans K, Pavan L, Auwerx J, Rochette-Egly C, Evain-Brion D, and Fournier T (2001) PPARgamma/RXRalpha heterodimers control human trophoblast invasion. J Clin Endocrinol Metab 86:5017-5024.
75. Trautman MS, Edwin SS, Collmer D, Dudley DJ, Simmons D, and Mitchell MD (1996) Prostaglandin H synthase-2 in human gestational tissues: regulation in amnion. Placenta 17:239-245.
76. Tsubouchi Y, Kawahito Y, Kohno M, Inoue K, Hla T, and Sano H (2001) Feedback control of the arachidonate cascade in rheumatoid synoviocytes by 15-deoxy-Delta(12,14)-prostaglandin J2. Biochem Biophys Res Commun 283:750-755.
77. Waite LL, Person EC, Zhou Y, Lim KH, Scanlan TS, and Taylor RN (2000) Placental peroxisome proliferator-activated receptor-gamma is up-regulated by pregnancy serum. J Clin Endocrinol Metab 85:3808-3814.